These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2549472)

  • 1. Effects of repeated treatment with haloperidol on rat striatal neutral endopeptidase, and on mu- and delta-opioid binding sites: comparison with chronic morphine and chronic kelatorphan.
    Delay-Goyet P; Zajac JM; Roques BP
    Neurosci Lett; 1989 Aug; 103(2):197-202. PubMed ID: 2549472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutral endopeptidase-24.11, mu and delta opioid receptors after selective brain lesions: an autoradiographic study.
    Waksman G; Hamel E; Delay-Goyet P; Roques BP
    Brain Res; 1987 Dec; 436(2):205-16. PubMed ID: 2829989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of significant changes in mu, delta opioid binding sites and neutral endopeptidase EC 3.4.24.11 in the brain and spinal cord of arthritic rats.
    Delay-Goyet P; Kayser V; Zajac JM; Guilbaud G; Besson JM; Roques BP
    Neuropharmacology; 1989 Dec; 28(12):1341-8. PubMed ID: 2559347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoradiographic comparison of the distribution of the neutral endopeptidase "enkephalinase" and of mu and delta opioid receptors in rat brain.
    Waksman G; Hamel E; Fournié-Zaluski MC; Roques BP
    Proc Natl Acad Sci U S A; 1986 Mar; 83(5):1523-7. PubMed ID: 3006054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further evidence for a role of delta-opiate receptors in the presynaptic regulation of newly synthesized dopamine release.
    Petit F; Hamon M; Fournie-Zaluski MC; Roques BP; Glowinski J
    Eur J Pharmacol; 1986 Jul; 126(1-2):1-9. PubMed ID: 3019709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of repeated administration of morphine, cocaine and ethanol on mu and delta opioid receptor density in the nucleus accumbens and striatum of the rat.
    Turchan J; Przewłocka B; Toth G; Lasoń W; Borsodi A; Przewłocki R
    Neuroscience; 1999; 91(3):971-7. PubMed ID: 10391475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding in vivo of selective mu and delta opioid receptor agonists: opioid receptor occupancy by endogenous enkephalins.
    Meucci E; Delay-Goyet P; Roques BP; Zajac JM
    Eur J Pharmacol; 1989 Nov; 171(2-3):167-78. PubMed ID: 2559856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterisation and visualisation of [3H]dermorphin binding to mu opioid receptors in the rat brain. Combined high selectivity and affinity in a natural peptide agonist for the morphine (mu) receptor.
    Amiche M; Sagan S; Mor A; Pelaprat D; Rostene W; Delfour A; Nicolas P
    Eur J Biochem; 1990 May; 189(3):625-35. PubMed ID: 2161761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The neutral endopeptidase-24.11 inhibitor SCH 34826 does not change opioid binding but reduces D1 dopamine receptors in rat brain.
    Trampus M; Ongini E; Varani K; Borea PA
    Eur J Pharmacol; 1991 Feb; 194(1):17-23. PubMed ID: 1647961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological and anatomical evidence of selective mu, delta, and kappa opioid receptor binding in rat brain.
    Mansour A; Lewis ME; Khachaturian H; Akil H; Watson SJ
    Brain Res; 1986 Dec; 399(1):69-79. PubMed ID: 3026574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ontogeny of mu and delta opioid receptors and of neutral endopeptidase in human spinal cord: an autoradiographic study.
    Salès N; Charnay Y; Zajac JM; Dubois PM; Roques BP
    J Chem Neuroanat; 1989; 2(4):179-88. PubMed ID: 2557052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [3H]ohmefentanyl preferentially binds to mu-opioid receptors but also labels sigma-sites in rat brain sections.
    Wang H; Pélaprat D; Roques BP; Vanhove A; Chi ZQ; Rostène W
    Eur J Pharmacol; 1991 Feb; 193(3):341-50. PubMed ID: 1647320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Affinity states of rat brain opioid receptors in different tissue preparations.
    Zajac JM; Bigeard A; Delay-Goyet P; Roques BP
    J Neurochem; 1990 Mar; 54(3):992-9. PubMed ID: 2154555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of intracerebroventricular beta-funaltrexamine on mu and delta opioid receptors in the rat: dichotomy between binding and antinociception.
    Liu-Chen LY; Li SX; Wheeler-Aceto H; Cowan A
    Eur J Pharmacol; 1991 Oct; 203(2):195-202. PubMed ID: 1666046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences of binding characteristics of non-selective opiates towards mu and delta receptor types.
    Delay-Goyet P; Roques BP; Zajac JM
    Life Sci; 1987 Aug; 41(6):723-31. PubMed ID: 3039270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphine and enkephalins potently inhibit [3H]noradrenaline release from rat brain cortex synaptosomes: further evidence for a presynaptic localization of mu-opioid receptors.
    Mulder AH; Hogenboom F; Wardeh G; Schoffelmeer AN
    J Neurochem; 1987 Apr; 48(4):1043-7. PubMed ID: 3029324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoradiographic distribution of mu and delta opiate receptors in rat brain using highly selective ligands.
    Quirion R; Zajac JM; Morgat JL; Roques BP
    Life Sci; 1983; 33 Suppl 1():227-30. PubMed ID: 6319867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in binding properties of mu and delta opioid receptor subtypes from rat brain: kinetic analysis and effects of ions and nucleotides.
    Zajac JM; Roques BP
    J Neurochem; 1985 May; 44(5):1605-14. PubMed ID: 2985757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kelatorphan, a potent enkephalinases inhibitor, and opioid receptor agonists DAGO and DTLET, differentially modulate self-stimulation behaviour depending on the site of administration.
    de Witte P; Heidbreder C; Roques BP
    Neuropharmacology; 1989 Jul; 28(7):667-76. PubMed ID: 2761678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of delta-opioid receptors reduces the in vivo binding of the cholecystokinin (CCK)-B-selective agonist [3H]pBC 264: evidence for a physiological regulation of CCKergic systems by endogenous enkephalins.
    Ruiz-Gayo M; Durieux C; Fournié-Zaluski MC; Roques BP
    J Neurochem; 1992 Nov; 59(5):1805-11. PubMed ID: 1357099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.